SIRT3 and neoplasm: Furthermore, a recent study revealed that SIRT3 negatively regulates pancreatic tumor growth by restraining malate-aspartate NADH shuttle, which is critical to sustain glycolysis in tumor cells, via deacetylating glutamate oxaloacetate transaminase (GOT2) [137].